Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class
- PMID:22037049
- PMCID: PMC3236098
- DOI: 10.1016/j.bmc.2011.10.007
Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class
Abstract
The demonstrated ability of amphetamine to functionally activate the rat trace amine associated receptor 1 (rTAAR1) and the subsequent reports of amphetamine activation of TAAR1 in rhesus monkey mouse, human, and human-rat chimeric TAAR1-expressing cell lines has led to speculation as to the role of this receptor in the central nervous system (CNS) responses associated with amphetamine and its analogs. The agonist potencies of ten pairs of enantiomeric amphetamines, including several with known CNS activity, at primate TAAR1 stably expressed in RD-HGA16 cells, robustly indicate the S-configuration to be associated with higher potency. Moreover, the rank order of potency to activate TAAR1 parallels the stimulant action reported by humans for the specific amphetamines. Taken together, these data suggest that TAAR1 is a stereoselective binding site for amphetamine and that activation of TAAR1 is involved in the modulation of the stimulant properties of amphetamine and its congeners. In addition, the observed parallel between hTAAR1 and rhTAAR1 responses supports the rhesus monkey as a highly translational model for developing novel TAAR1-directed compounds as therapeutics for amphetamine-related addictions.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
Similar articles
- Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.Panas HN, Lynch LJ, Vallender EJ, Xie Z, Chen GL, Lynn SK, Scanlan TS, Miller GM.Panas HN, et al.J Neurosci Res. 2010 Jul;88(9):1962-9. doi: 10.1002/jnr.22367.J Neurosci Res. 2010.PMID:20155805Free PMC article.
- Exploring the determinants of trace amine-associated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine.Reese EA, Norimatsu Y, Grandy MS, Suchland KL, Bunzow JR, Grandy DK.Reese EA, et al.J Med Chem. 2014 Jan 23;57(2):378-90. doi: 10.1021/jm401316v. Epub 2014 Jan 7.J Med Chem. 2014.PMID:24354319
- Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.Revel FG, Meyer CA, Bradaia A, Jeanneau K, Calcagno E, André CB, Haenggi M, Miss MT, Galley G, Norcross RD, Invernizzi RW, Wettstein JG, Moreau JL, Hoener MC.Revel FG, et al.Neuropsychopharmacology. 2012 Nov;37(12):2580-92. doi: 10.1038/npp.2012.109. Epub 2012 Jul 4.Neuropsychopharmacology. 2012.PMID:22763617Free PMC article.
- Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present).Tonelli M, Cichero E.Tonelli M, et al.Expert Opin Ther Pat. 2020 Feb;30(2):137-145. doi: 10.1080/13543776.2020.1708900. Epub 2019 Dec 25.Expert Opin Ther Pat. 2020.PMID:31865810Review.
- In-vivo pharmacology of Trace-Amine Associated Receptor 1.Lam VM, Espinoza S, Gerasimov AS, Gainetdinov RR, Salahpour A.Lam VM, et al.Eur J Pharmacol. 2015 Sep 15;763(Pt B):136-42. doi: 10.1016/j.ejphar.2015.06.026. Epub 2015 Jun 17.Eur J Pharmacol. 2015.PMID:26093041Review.
Cited by
- Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking.Pei Y, Lee J, Leo D, Gainetdinov RR, Hoener MC, Canales JJ.Pei Y, et al.Neuropsychopharmacology. 2014 Sep;39(10):2299-308. doi: 10.1038/npp.2014.88. Epub 2014 Apr 11.Neuropsychopharmacology. 2014.PMID:24722355Free PMC article.
- Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases.Padivitage NL, Dodbiba E, Breitbach ZS, Armstrong DW.Padivitage NL, et al.Drug Test Anal. 2014 Jun;6(6):542-51. doi: 10.1002/dta.1534. Epub 2013 Sep 20.Drug Test Anal. 2014.PMID:24115758Free PMC article.
- Trace amine-associated receptor 1 and drug abuse.Wu R, Liu J, Li JX.Wu R, et al.Adv Pharmacol. 2022;93:373-401. doi: 10.1016/bs.apha.2021.10.005. Epub 2021 Nov 11.Adv Pharmacol. 2022.PMID:35341572Free PMC article.
- Molecular Mechanisms of Methamphetamine-Induced Addiction via TAAR1 Activation.Lin Y, Wang J, Shi F, Yang L, Wu S, Qiao A, Ye S.Lin Y, et al.J Med Chem. 2024 Oct 24;67(20):18593-18605. doi: 10.1021/acs.jmedchem.4c01961. Epub 2024 Oct 2.J Med Chem. 2024.PMID:39358311Free PMC article.
- Methamphetamine Use and Cardiovascular Disease.Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, Arnold CL, Traylor JG, Orr AW.Kevil CG, et al.Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1739-1746. doi: 10.1161/ATVBAHA.119.312461. Epub 2019 Aug 21.Arterioscler Thromb Vasc Biol. 2019.PMID:31433698Free PMC article.Review.
References
- Shulgin AT, Sargent T, Naranjo C. Nature. 1969;221:537. - PubMed
- Glennon RA, Young R. Pharm Biochem Behav. 2002;72:307. - PubMed
- Branchek T, Adham N, Macchi M, Kao HT, Hartig PR. Mol Pharmacol. 1990;38:604. - PubMed
- Leonhardt S, Titeler M. J Neurochem. 1989;53:316. - PubMed
- Pierce PA, Peroutka SJ. J Neurochem. 1989;52:656. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
- DA025802/DA/NIDA NIH HHS/United States
- R03 DA025802/DA/NIDA NIH HHS/United States
- RR00168/RR/NCRR NIH HHS/United States
- K02 DA025697/DA/NIDA NIH HHS/United States
- R01 DA016327/DA/NIDA NIH HHS/United States
- R21 NS064780-01A1/NS/NINDS NIH HHS/United States
- R03 DA025802-01/DA/NIDA NIH HHS/United States
- R21 NS064780/NS/NINDS NIH HHS/United States
- 1R21NS064780-01A1/NS/NINDS NIH HHS/United States
- P51 RR000168/RR/NCRR NIH HHS/United States
- K26 RR000168/RR/NCRR NIH HHS/United States
- R01 DA016327-01A2/DA/NIDA NIH HHS/United States
- R01-DA016327/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Chemical Information
Molecular Biology Databases
Miscellaneous